LAM supports a wide range of innovative investment strategies. These strategies span across both private and public markets.
Pan Asia Multi-Strategy
Asia-focused multi-manager platform investing across equities, credit, fixed income/rates, FX, and commodities within the region.
Multi-Manager Equity Investing
Market-neutral equity platform focused on fundamental and tactical trading strategies across the U.S., Europe, and Asia.
Multi-Manager “First Loss” Model
First-loss, multi-manager and multi-strategy liquid securities platform.
Multi-PM, fundamental equity market-neutral platform built on proprietary insights into where alpha resides within equity markets.
Asset Backed Securities
Total return strategy focused on the cash securitized products market through investments in consumer-oriented asset-backed securities.
Distressed Credit & Special Situations
Distressed and special situations long/short credit strategy investing across sectors and asset types.
Asset-Based & Opportunistic Credit
Diversified asset manager specializing in distressed and event-driven opportunities across structured credit, opportunistic credit, and private credit.
Long/Short Bank Credit
Long/short strategy specializing in bank credit-related instruments
Private credit platform offering investment programs across mid-cap and large cap direct lending, broadly syndicated loans and CLOs.
European Opportunistic Credit
Pan-European fundamental credit strategy focused on idiosyncratic opportunities with high execution complexity.
Private corporate credit strategy deploying capital into short-dated receivables, focusing on the inefficiencies of the bespoke trade finance marketplace.
EQUITY LONG / SHORT
TMT Long/Short Equity
Fundamental long/short equity strategy focused on the TMT, Consumer, Travel, Leisure and Gaming sectors globally.
Energy & Industrials
Global long/short equity strategy specializing in energy and related cyclical sectors with a focus on industries driven by global supply/demand chains.
China Long/Short Equity
Hong Kong-based, Greater China-focused long/short equity manager employing a fundamental approach to identifying long-term investments backed by structural mega trends.
Healthcare Long/Short Equity
Fundamental, science-driven long/short equity strategy focused on providing exposure to specific disease indications through investments in biopharma companies